Journals / Türk Biyokimya Dergisi / 2021 / Cilt: 46 - Sayı: 3

The method comparison and the verification of precision of Mindray CL-6000i thyroid function tests (TFTs)

Pages
255–262
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Mindray CL-6000i had good precision in all tests, but the difference between the two methods in some tests shows that the harmonization and standardization of TFTs initiated globally is required.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Thyroid diseases are the most frequent endocrine disorders and thyroid function tests (TFTs) are the most commonly requested endocrine tests.
📊
Key Findings & Data:The aim of our study was to determine the bias and to verify the precision of the newly introduced Mindray CL-6000i immunoassay system in the guidance of CLSI guidelines.
💡
Conclusion & Impact:Conclusions: Mindray CL-6000i had good precision in all tests, but the difference between the two methods in some tests shows that the harmonization and standardization of TFTs initiated globally is required.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Thyroid diseases are the most frequent endocrine disorders and thyroid function tests (TFTs) are the most commonly requested endocrine tests. The reliable measurements of these tests are quite important. The aim of our study was to determine the bias and to verify the precision of the newly introduced Mindray CL-6000i immunoassay system in the guidance of CLSI guidelines. Methods: A precision and bias study was performed in Mindray CL-6000i analyzer for FT3, FT4, TSH, Anti-TG, and Anti-TPO tests by using BioRad quality control (QC) materials and serum samples, respectively. Bland–Altman difference plot and Passing-Bablok regression analysis was made for method comparison with Beckman Coulter DXI 800 analyzer. Results: The repeatability coefficient of variations (CVs) of FT3, FT4, TSH, Anti-TG, and Anti-TPO tests were ≤2.36, ≤1.66, ≤2.38, ≤3.48, and ≤3.31% while within laboratory CVs were ≤2.85, ≤4.61, ≤2.59, ≤3.78, and ≤3.60%, respectively. The mean differences between the two methods obtained from Bland–Altman analysis for FT3, FT4, TSH, Anti-TG, and Anti-TPO were defined to be −19%, 1.95%, −5.9%, −3.5%, and 7.3%, respectively. Conclusions: Mindray CL-6000i had good precision in all tests, but the difference between the two methods in some tests shows that the harmonization and standardization of TFTs initiated globally is required.

🔖

Cite This Article

BOZKAYA, G., ŞİŞMAN, A. R. (2021). The method comparison and the verification of precision of Mindray CL-6000i thyroid function tests (TFTs). Türk Biyokimya Dergisi, Cilt: 46 - Sayı: 3, 255–262. https://ajindex.com/articles/394983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Soh SB, Aw TC. Laboratory testing in thyroid conditions-pitfalls and clinical utility. Ann Lab Med 2019;39:3–14
  2. Thienpont LM, Van Uytfanghe K, Poppe K, Velkeniers B. Determination of free thyroid hormones. Best Pract Res Clin Endocrinol Metab 2013;27:689–700
  3. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160:1573–75
  4. Singh RJ, Kaur P. Thyroid hormone testing in the 21st century. Clin Biochem 2016;49:843–45
  5. Sheehan MT. Biochemical testing of the thyroid: TSH is the best and, often times, only test needed-a review for primary care. Clin Med Res 2016;14:83–92
  6. Iervasi G, Clerico A. Harmonization of free thyroid hormone test: a mission impossible?. Clin Chem Lab Med 2011;49:43–8
  7. Spencer CA. Assay of thyroid hormones and related substances. Thyroid disease manager. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2013 Jan 1
  8. Rawlins ML, Roberts WL. Performance characteristics of six third generation assays for thyroid-stimulating hormone. Clin Chem 2004;50:2338–44
  9. Dittadi R, Rizzardi S, Masotti S, Prontera C, Ripoli A, Fortunato A, et al. Multicenter evaluation of the new immunoassay method for TSH measurement using the automated DxI platform. Clin Chim Acta 2017;468:105–10
  10. Thienpont LM, Faix JD, Beastall G. Standardization of FT4 and harmonization of TSH measurements – a request for input from endocrinologists and other physicians. Clin Endocrinol (Oxf) 2016;84:305–6
  11. Padoan A, Cosma C, Plebani M. Evaluation of the analytical performances of six measurands for thyroid functions of Mindray CL-2000i system. J Lab Precis Med 2018;3:1–7
  12. Miller GW, Myers GL, Lou Gantzer M, Kahn SE, Schonbrunner ER, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57: 1108–17
  13. Thienpont LM, Van Houcke SK. Traceability to a common standard for protein measurements by immunoassay for in-vitro diagnostic purposes. Clin Chim Acta 2010;411:2058–61
  14. Thienpont LM, Van Uytfanghe K, De Grande LAC, Reynders D, Das B, Faix JD, et al. Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval. Clin Chem 2017;63:1248–1260
  15. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ,